Senseonics Holdings (SENS) Net Equity Issued and Repurchased (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Net Equity Issued and Repurchased came in at $3.5 million in Q1 2026, down 86.8% year-on-year from $26.5 million in Q1 2025, and up 114.68% on a QoQ basis from -$23.8 million in Q4 2025.
Senseonics Holdings (SENS) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $3.5 million in Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased fell 86.8% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 79.94% decrease from a year earlier, with the FY2025 full-year figure at $28.3 million, up 642.36% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $3.5 million, up from -$23.8 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for SENS reached as high as $34.4 million in Q1 2023 and fell as low as -$27.0 million in Q2 2023.
- Historically, Net Equity Issued and Repurchased has averaged $4.7 million across 5 years, with a median of $3.5 million in 2026.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 26356.0% in 2025 and fell as far as 16181.76% in 2025.
- Year by year, Net Equity Issued and Repurchased stood at -$22.4 million in 2022, then slipped by 20.54% to -$27.0 million in 2023, then jumped by 100.55% to $148000.0 in 2024, then slumped by 16181.76% to -$23.8 million in 2025, then soared by 114.68% to $3.5 million in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $3.5 million in Q1 2026, -$23.8 million in Q4 2025, and $25.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | 3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.49 Mn |
| Mar 31, 2026 | 3.49 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Jun 30, 2025 | 25.67 Mn |
| Jun 30, 2025 | 25.67 Mn |
| Mar 31, 2025 | 26.46 Mn |
| Mar 31, 2025 | 26.46 Mn |
| Dec 31, 2024 | 148,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Jun 30, 2023 | -27.00 Mn |
| Jun 30, 2023 | -27.00 Mn |
| Mar 31, 2023 | 34.40 Mn |
| Mar 31, 2023 | 34.40 Mn |
| Dec 31, 2022 | -22.40 Mn |
| Dec 31, 2022 | -22.40 Mn |
| Sep 30, 2022 | 26.40 Mn |
| Sep 30, 2022 | 26.40 Mn |